Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.
Hedin CRH, Sado G, Ndegwa N, Lytvyak E, Mason A, Montano-Loza A, Gerussi A, Saffioti F, Thorburn D, Nilsson E, Larsson G, Moum BA, van Munster KN, Ponsioen CY, Levy C, Nogueira NF, Bowlus CL, Gotlieb N, Shibolet O, Lynch KD, Chapman RW, Rupp C, Vesterhus M, Jørgensen KK, Rorsman F, Schramm C, Sabino J, Vermeire S, Zago A, Cazzagon N, Marschall HU, Ytting H, Ben Belkacem K, Chazouilleres O, Almer S; International PSC Study Group; Bergquist A. Hedin CRH, et al. Among authors: shibolet o. Clin Gastroenterol Hepatol. 2020 Sep;18(10):2295-2304.e2. doi: 10.1016/j.cgh.2020.02.014. Epub 2020 Feb 15. Clin Gastroenterol Hepatol. 2020. PMID: 32068151
Adalimumab-induced autoimmune hepatitis.
Adar T, Mizrahi M, Pappo O, Scheiman-Elazary A, Shibolet O. Adar T, et al. Among authors: shibolet o. J Clin Gastroenterol. 2010 Jan;44(1):e20-2. doi: 10.1097/MCG.0b013e3181a745e7. J Clin Gastroenterol. 2010. PMID: 19593165
Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease.
Yanai H, Matalon S, Rosenblatt A, Awadie H, Berdichevski T, Snir Y, Kopylov U, Katz L, Stein A, Mlynarsky L, Tulchinsky H, Konikoff FM, Horin SB, Braun M, Ben-Ari Z, Chowers Y, Baruch Y, Shibolet O, Dotan I. Yanai H, et al. Among authors: shibolet o. J Crohns Colitis. 2015 Feb;9(2):177-84. doi: 10.1093/ecco-jcc/jju013. J Crohns Colitis. 2015. PMID: 25518055
Identification and Characterization of Nonalcoholic Fatty Liver Disease.
Goldshtein I, Chodick G, Kochba I, Gal N, Webb M, Shibolet O. Goldshtein I, et al. Among authors: shibolet o. Clin Gastroenterol Hepatol. 2020 Jul;18(8):1887-1889. doi: 10.1016/j.cgh.2019.08.007. Epub 2019 Aug 9. Clin Gastroenterol Hepatol. 2020. PMID: 31404663
Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis.
Greverath LM, Leicht E, Wald de Chamorro N, Wilde AB, Steinhagen LM, Lieb C, Schmelzle M, Chopra S, Shibolet O, Fischer J, Berg T, Tacke F, Müller T. Greverath LM, et al. Among authors: shibolet o. Hepatol Res. 2020 Mar;50(3):321-329. doi: 10.1111/hepr.13455. Epub 2019 Dec 3. Hepatol Res. 2020. PMID: 31747477
174 results